The Latest Breaking News from NCI

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology startups, federal agencies and private foundations. As a cancer biologist who has worked in each of these sectors over the past three…

NCI allocates millions for DEI in medicine, facing criticism and changes under different administrations.

One in five U.S. adults thinks alcohol has “no effect” on their risk of developing the deadly disease.

Universal Health (UHS) reported robust financial results in the last quarter and raised its full-year outlook. The company's widespread operations, reputation, and high profitability continue to drive growth. So, let’s analyze whether it is the right time to buy, sell or hold UHS before its earnings. Read more to find…

The change in latitude (price levels) of old-crop and new-crop corn is changing the attitude toward both markets.

When looking at the different aspects of the corn market as a long-term investment opportunity, we can use different studies to evaluate its value and growth potential.

Nationwide colorectal cancer incidence and mortality rates have fallen since 2000, but rates have been increasing among younger adults for several years.

Alka Dwivedi and team develop affordable CAR-T cell therapy in India, revolutionizing cancer treatment accessibility.

It's April 1, 2024. Has King Corn turned bullish based on the reaction to one set of government numbers?